Sabrina Poole

1.5k total citations
24 papers, 1.2k citations indexed

About

Sabrina Poole is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Sabrina Poole has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Public Health, Environmental and Occupational Health and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Sabrina Poole's work include Opioid Use Disorder Treatment (13 papers), Substance Abuse Treatment and Outcomes (11 papers) and Prenatal Substance Exposure Effects (9 papers). Sabrina Poole is often cited by papers focused on Opioid Use Disorder Treatment (13 papers), Substance Abuse Treatment and Outcomes (11 papers) and Prenatal Substance Exposure Effects (9 papers). Sabrina Poole collaborates with scholars based in United States, Canada and Spain. Sabrina Poole's co-authors include George Woody, Geetha Subramaniam, Joseph R. Volpicelli, Kevin G. Lynch, James Cornish, Charles P. O’Brien, Robert Gallop, Barbara Flannery, Jennifer Sharpe Potter and Ashwin A. Patkar and has published in prestigious journals such as JAMA, Journal of the American Academy of Child & Adolescent Psychiatry and Clinical Pharmacology & Therapeutics.

In The Last Decade

Sabrina Poole

23 papers receiving 1.2k citations

Peers

Sabrina Poole
R. Jeffrey Goldsmith United States
Karen Drexler United States
Mary Ann Chutuape United States
Paul A. Nuzzo United States
Thomas Kosten United States
Carlos Zúbaran Australia
Stephen T. Higgins United States
Emily B. Einstein United States
Laura F. McNicholas United States
Peter Banys United States
R. Jeffrey Goldsmith United States
Sabrina Poole
Citations per year, relative to Sabrina Poole Sabrina Poole (= 1×) peers R. Jeffrey Goldsmith

Countries citing papers authored by Sabrina Poole

Since Specialization
Citations

This map shows the geographic impact of Sabrina Poole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabrina Poole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabrina Poole more than expected).

Fields of papers citing papers by Sabrina Poole

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabrina Poole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabrina Poole. The network helps show where Sabrina Poole may publish in the future.

Co-authorship network of co-authors of Sabrina Poole

This figure shows the co-authorship network connecting the top 25 collaborators of Sabrina Poole. A scholar is included among the top collaborators of Sabrina Poole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabrina Poole. Sabrina Poole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jalali, Ali, Philip J. Jeng, Daniel Polsky, et al.. (2022). Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid use disorder before release from prison versus after release. Journal of Substance Abuse Treatment. 141. 108835–108835. 7 indexed citations
2.
Woody, George, Sabrina Poole, Elmer Yu, John D. Carroll, & Kevin G. Lynch. (2021). Extended release injectable naltrexone before vs. after release: A randomized trial of opioid addicted persons who are in prison. Journal of Substance Abuse Treatment. 127. 108355–108355. 8 indexed citations
3.
Murphy, Sean M., Philip J. Jeng, Sabrina Poole, et al.. (2020). Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials. Addiction Science & Clinical Practice. 15(1). 15–15. 14 indexed citations
4.
5.
Poole, Sabrina, Anna Pecoraro, Geetha Subramaniam, George Woody, & Victoria L. Vetter. (2015). Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth with Opioid Dependence. Journal of Addiction Medicine. 10(1). 26–33. 13 indexed citations
6.
Woody, George, Douglas Bruce, P. Todd Korthuis, et al.. (2014). HIV Risk Reduction With Buprenorphine–Naloxone or Methadone. JAIDS Journal of Acquired Immune Deficiency Syndromes. 66(3). 288–293. 76 indexed citations
7.
Otiashvili, David, et al.. (2014). Opioid Addicted Buprenorphine Injectors: Drug Use During and After 12-Weeks of Buprenorphine–Naloxone or Methadone in the Republic of Georgia. Journal of Substance Abuse Treatment. 50. 32–37. 12 indexed citations
8.
Warden, Diane, Geetha Subramaniam, Thomas Carmody, et al.. (2012). Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth. Addictive Behaviors. 37(9). 1046–1053. 57 indexed citations
9.
Subramaniam, Geetha, Diane Warden, Abu Minhajuddin, et al.. (2011). Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth. Journal of the American Academy of Child & Adolescent Psychiatry. 50(11). 1120–1128. 46 indexed citations
10.
Meade, Christina S., Roger D. Weiss, Garrett M. Fitzmaurice, et al.. (2010). HIV Risk Behavior in Treatment-Seeking Opioid-Dependent Youth: Results From a NIDA Clinical Trials Network Multisite Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(1). 65–72. 26 indexed citations
11.
Polsky, Daniel, Henry A. Glick, Jianing Yang, et al.. (2010). Cost‐effectiveness of extended buprenorphine–naloxone treatment for opioid‐dependent youth: data from a randomized trial. Addiction. 105(9). 1616–1624. 61 indexed citations
12.
Woody, George, Sabrina Poole, Geetha Subramaniam, et al.. (2009). Extended vs. short-term buprenorphinenaloxone for treatment of opioid addicted youth: A randomized trial. The Canadian Journal of Addiction. 1(1). 39–40. 30 indexed citations
13.
Woody, George, Sabrina Poole, Geetha Subramaniam, et al.. (2008). Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth. JAMA. 300(17). 2003–11. 274 indexed citations
14.
Dackis, Charles A., Kevin G. Lynch, Elmer Yu, et al.. (2003). Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug and Alcohol Dependence. 70(1). 29–37. 150 indexed citations
15.
Kampman, Kyle M., Maria Dorota Majewska, Karen A. Tourian, et al.. (2003). A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence. Addictive Behaviors. 28(3). 437–448. 14 indexed citations
16.
Flannery, Barbara, Sabrina Poole, Robert Gallop, & Joseph R. Volpicelli. (2003). Alcohol craving predicts drinking during treatment: an analysis of three assessment instruments.. Journal of Studies on Alcohol. 64(1). 120–126. 128 indexed citations
17.
Cornish, James, Barbara H. Herman, Ronald N. Ehrman, et al.. (2002). A randomized, double-blind, placebo-controlled safety study of high-dose dextromethorphan in methadone-maintained male inpatients. Drug and Alcohol Dependence. 67(2). 177–183. 20 indexed citations
18.
Kampman, Kyle M., Joseph R. Volpicelli, Frank D. Mulvaney, et al.. (2001). Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. Drug and Alcohol Dependence. 63(1). 69–78. 98 indexed citations
19.
Romach, Myroslava K., Kyle M. Kampman, Paul Glue, et al.. (1999). Ecopipam (SCH 39166), A D1 antagonist, on acute effects of cocaine. Clinical Pharmacology & Therapeutics. 65(2). 146–146. 1 indexed citations
20.
Cornish, James, et al.. (1995). Carbamazepine treatment for cocaine dependence. Drug and Alcohol Dependence. 38(3). 221–227. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Jeffrey Goldsmith Breakdown of academic impact, for papers by Karen Drexler Breakdown of academic impact, for papers by Mary Ann Chutuape Breakdown of academic impact, for papers by Paul A. Nuzzo Breakdown of academic impact, for papers by Thomas Kosten Breakdown of academic impact, for papers by Carlos Zúbaran Breakdown of academic impact, for papers by Stephen T. Higgins Breakdown of academic impact, for papers by Emily B. Einstein Breakdown of academic impact, for papers by Laura F. McNicholas Breakdown of academic impact, for papers by Peter Banys
Rankless by CCL
2026